Zach is a biotech investor with PhD training in Biochemistry and Molecular Biology. In real life, he is a scientific writer specializing in continuing medical education. He hopes to provide a crucial piece of total due diligence as well as interesting insight into clinical findings that may impact readers' portfolios and lives.
I am a financial adviser and Registered Investment Adviser specializing in emerging growth stocks. I am also a market technician with an article written in the Wall Street Journal about one of my market hedging techniques (Google: Moving The Market-Tracking The Numbers, Edward Levi, The Wall Street Journal). I've spent 11 years at Dean Witter, 18 at Smith Barney, and 8 at Morgan Stanley. I've decided to join Beverly Hills Wealth Management so that I can concentrate on building private hedge fund portfolios for clients, whether related to growth or income, or both.
I specialize in emerging growth investments that run the gamut from medical devices and therapies, technology, and alternative energy.
I've spent a lifetime of research in the technical aspects of the market, measuring market sentiment, momentum, and chart patterns. For many years I've given market presentations to financial advisers at Smith Barney and Morgan Stanley showing extremes in sentiment and chart patterns. I have my own proprietary indicators that measure extremes and hedge clients portfolios at times when protection is in order. My goal is to be fully invested in the rising trends but very protective of portfolios when sentiment and momentum indicators reach extremes. I'm usually early in predicting trends but usually right. Extreme sentiment is a leading indicator, and I believe it precludes market and economic fundamentals as a source of knowledge of changing trends.
Individual Investor with a preference for long-term value-oriented investments that are based on in-depth research & understanding of the company's products and markets. Educational background includes mechanical engineering and MBA (Finance) degrees.
Long-time individual investor who began trading in mid-90's. My philosophy is to identify "value gaps" between what I believe a company to be worth today versus it's stock price. I do not follow charts or technicals, but rather look to find companies with stock prices that move out of sync with the value of recent news to find and (hopefully) capitalize on these value gaps.
Over 30 years of investing in individual stocks. Extensive business experience with small to mid-size companies, including as CEO. Many hundreds of blog posts on financial and economic matters since 2008. Focus on value with catalysts for upside price action. Background as a physician and pharmaceutical inventor and entrepreneur, however focus now is global and involves almost all economic categories.
I spend most of my time reading through annual reports looking for a small-cap stock to feature in my monthly edition of "The Conservative Investor Digest." That is where you can find my best work, and that is where I focus my research. You can become a subscriber here: https://gumroad.com/l/HmqJx
My name is Dr Kanak Kanti De, MBBS, MD, PhD, retired medical practitioner, cancer survivor, healthcare sector investor, over 30 years' experience in the sector both in India and the United States. I write/have written on Motley Fool, SeekingAlpha, Benzinga, and on Forbes. I am consistently ranked high on TipRanks, although I don't like their ranking system. My portfolio has consistently beat the various indices for years. Email me to discuss my articles, or for just an adda (Bengali for informal chat) email@example.com.
Author of the critically acclaimed book, "Taking Charge With Value Investing (McGraw-Hill, 2013)" and the premium subscription service "Tipping The Scale" (as seen below). An analyst that ranks in the top 4% on both tipranks.com and Motley Fool CAPS for stock picking performance.
Tipping the Scale members gain access to the TTS Portfolio Tracker. Here, members see what I am buying and selling the minute it happens, along with what I have owned, bought, and sold historically. These are just a few of the features on the TTS Portfolio Tracker.
Tipping The Scale is an equity research platform that uses a numeric scale instead of the traditional "Buy, Hold, Sell" to identify the best investment opportunities in the market. Stock coverage is determined by market catalyst, and every company goes through a vigorous test in 10 different categories. The higher the total score, the bigger the upside. In addition, Tipping the Scale also provides a number of portfolio strategies to hedge the volatility of the market and protect from downside.
Check out my instablog for more information on the popular research service Tipping the Scale, including performance information, benefits, and how it all works.
I'm a capital projects manager and process design engineer at a large-cap biotech company. I love the financial world because it is like one big puzzle and I hope we the Seeking Alpha Community help each other out to solve the puzzle to help us realize our dreams.
Finance professional with extensive experience analyzing companies. I have an innate passion for finance and investing. While most popular stock prognosticators tell investors what they want to hear, I try to inform investors about what they need to know to make an informed decision.
Disclaimer: Articles and/or comments represent the opinion of the author, who is not a licensed financial advisor. Articles are intended for informational and educational purposes only, and should not be construed as investment advice to any particular individual. Readers should perform their own due diligence before making any investment decisions.
I work in the natural gas industry for and I have spent the last 2-3 years researching all aspects of the the booming NGV industry. My investment horizon is typically no shorter than 3-5 years and I am currently heavily invested in NGV related companies.
John is the author of Purple Chips (published by John Wiley & Sons, 2012). John began his 28 year investment career as a floor trader in 1984 after completing a B.Comm (Finance) at Concordia University. John is also a Lead Judge for the John Molson International MBA Case Competition and now works as a Portfolio Manager where he manages investment portfolios over $500,000.
I am an individual investor who has been actively involved in the healthcare and biotechnology space for over 15 years. I hold a PhD in the biomedical sciences and have worked in both large pharmaceutical and small biotech companies. I make investments based on the fundamentals of a company and if I believe they have a superior technology or products compared to the competition. I'm an investor who believes patience pays off.
I personally started investing in equities in 1997 and after the bust of the dot-com bubble, switched my focus to systematic approaches. The following decade of research built the foundation of Boavista Capital Management, which I founded in 2014.
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage.
The purpose of this profile is to allow us to share with our readers new transcript-related developments.
SA Transcripts Team
Equity Flux offers its clients financial consultancy services. We pride ourselves on our ability to provide you with the latest research, news, views and opinions. We aim to build long term relationships by helping our clients and partners create sustainable value for their own businesses.
Simple qualitative analysis is a key component of every investment thesis. I am particularly good at keeping it simple and to the point. My analysis focuses on finding undervalued opportunity in growth industries. I am a long term investor working to buy great companies with a great story at a great price.
I hold a PhD in Electrical Engineering (Control Theory) from Stanford University and a Masters Degree in Engineering-Economic Systems (now called Management Science and Engineering at Stanford).
I have been fascinated by the stock market since I was 14 (that is 37 years ago at writing). It has always struck me as the place to be.
In the last 10+ years I moved from what I would call the "herd mentality" to a more educated process. In particular, my years as a Principal Software Engineer in a derivatives software development company, interacting closely with Financial Engineers, showed me clearly the simple science behind this: "Mean Reversion is All We Know about the Game!"
Robert Hauver, MBA, is a Registered Investment Advisor Representative. He publishes The Double Dividend Stock Alert, a monthly investment newsletter that features the best dividend stocks and option selling strategies for income investors.
TipRanks rates DoubleDividendStocks in the Top 25 of all financial bloggers.
The https://www.DoubleDividendStocks.com website also features High Dividend Stocks By Sector Tables, and Covered Calls & Cash Secured Puts Tables, a Dividend Stocks blog, and a a Stock Market News & Data page. 845-225-4094
The reports that I write are my personal research and opinions. They are not associated with any firm or organization, and are not intended to be taken as investment recommendations or advice. They combine my passions of economics, finance, writing and education, and are intended mostly as educational material. I attempt to write the articles in an easy to understand down to earth style in an effort to help others with their research. This is my effort to bring understandable and educational professional quality research to the public at large free of charge.
General Disclaimer for my Articles:
BS Business, Majored in Finance and Economics, Miami University
MA Economics w/ Managerial and International Emphasis, University of Oklahoma
Past: Economics and Finance Instructor at various Universities
Past: Mutual Fund Portfolio Manager of Family of Mutual Funds
Past: CIO of Mid-Sized Investment Management Firm
Professional: CFA Charterholder
Please note that the content of this site should not be construed as investment advice, nor do the opinions expressed necessarily reflect the views of CFA Institute.
I'm an asset manager at Hebba Alternative Investments with a focus on real assets. In my articles I like to focus on events that affect the macro environment for assets (especially gold and silver), and also introduce readers to different metrics that I believe are under-utilized when assessing investments.
On a more personal note, I'm a firm believer that there can be honesty, morality, and integrity in finance (though its rare) and i'd like to believe that I stick to those principles. Thus I never "pump and dump" stocks, I always list the securities we own, and I take it very seriously when I recommend a company - I do not want to see any investors/readers lose money because of my recommendations.
I'm not always right with recommendations, but investors and readers can know that I always tell the truth (there is no deception) and I eat my own cooking as recommendations are either always owned OR the reason I dont own them is given (usually related to restrictions on stocks I can buy).
Advising people in financial matters is a serious issue and integrity is much more important than money to me, but I do believe both can co-exist. You live with money, but after your death you only have your morality and integrity and thus i've made my choice between the two. A bit philosophical for a bio, but I dont think there's a better way to give investors my background than that.
We offer investors a free weekly email list detailing gold, silver, and general economic markets which you can sign up for at: http://www.communitysynergy.com/subscribe/hebbainvestments_subscribe.html
Yaron “Ron” Reuven is the President & Chief Investment Officer of Reuven Capital Investments, LP. His expertise is in business valuations, financial model & theory analysis, and financial industry compliance. Throughout his 15 year career, Ron has been a valuable asset to many business owners and executives by managing their investments as well as advising them on countless business matters. Ron began his American dream at the age of 10 when his family emigrated from Israel to the United States. He became involved in business early on and has been exposed to a variety of industries and business models. This eclectic experience has cemented his distinctive investment and business philosophy. Establishing a FINRA MEMBER BROKER/DEALER when he was just 26 years old made Mr. Reuven one of the youngest individuals to ever independently open a FINRA member firm. Ron’s contrarian point of view and broad range of management, financial, and investment experience offers a unique value to the firm’s clients.
Yaron “Ron” Reuven began his career in the financial services industry at a New York City branch of First Union in 1999. There he began developing his own due diligence process and investment philosophy. By mid 2001, he was recruited by Raymond James Financial (NYSE:RJF), one of the largest financial services firms in the United States. At Raymond James, he began to implement his own concentrated investment philosophy and built strong relationships with his clients. Throughout one of the most difficult environments in market history Ron successfully became the third largest producing broker in the United States for Raymond James in August 2003.
Subsequently in an effort to expand the services and products he was able to offer his clients, Ron started a Wall Street office with another national independent broker/dealer based in Florida. He quickly became the firm’s largest producing broker and branch. In order to truly accomplish his long term goals, he realized that he and his team needed to be completely independent. In November 2006 REUVEN ENTERPRISES SECURITIES DIVISION (RESD) A FINRA/SIPC MEMBER FIRM AND MSRB LICENSED DEALER was founded. This was a massive undertaking which allowed Ron to truly implement his long term investment philosophy, and ultimately launch his hedge fund. In 2009 REUVEN CAPITAL INVESTMENTS, LP FUND (RCI) was launched. RCI is a long/short equity fund with a selectively concentrated portfolio. Ron’s ultimate goal for RCI is to have shareholder representation on the board of some of the companies the fund invests in.
Mr. Reuven is a NFL PLAYERS ASSOCIATION REGISTERED PLAYER FINANCIAL ADVISOR, and is involved with multiple charitable organizations, philanthropic work and public speaking. His unique philosophy, track record, and incisive financial commentary have been featured by Bloomberg, CNBC, NDTV, SNN WIRE, MANN, CNN, and GotGame.
MR. YARON “RON” REUVEN HOLDS THE FOLLOWING LICENSES:
Registered Options Principal (Series 4)
General Securities Representative (Series 7),
General Securities Principal (Series 24),
Municipal Securities Principal (Series 53),
Uniform Securities Agent State Law (Series 63),
Investment Banking Representative (Series 79)
Licensed Operations Professional (Series 99)
Licensed Life Insurance Agent and Registered Financial Planner RFP®
and CEO of Member FINRA Broker Dealer.
Howard is the CEO and co-founder of Black Mountain Capital Management, developers of Stock Rover.
Prior to that he founded a company called Heroix, which has now been in business for 35 years providing advanced system management software for large scale corporate data centers. Howard's expertise is in engineering large scale enterprise class software systems. He remains the Chairman of the Board of Heroix Corp.
Howard is Phi Beta Kappa and magna cum laude graduate of Brown University, where he earned degrees in mathematics and in economics.
He is passionate about investing.
Ashraf Eassa is a technology specialist with The Motley Fool. He writes mostly about technology stocks, but is especially interested in anything related to chips -- the semiconductor kind, that is.
Economist based in the UK. Earlier career in founding businesses and start-ups before a brief spell in academia (Warwick Business School); moved to high end economic consulting for leading firm of economists, before returning to help new businesses grow. Net estimated gain to client worth around $200m over the last decade.
I have actively traded stocks since 2010 based on fundamental analysis and my own quantitative forecasting methods.